Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Role of WNT7B-induced noncanonical pathway in advanced prostate cancer
Dali Zheng
, Keith F. Decker
, Tianhua Zhou
, Jianquan Chen
, Zongtai Qi
, Kathryn Jacobs
,
Katherine N. Weilbaecher
, Eva Corey
, Fanxin Long
, Li Jia
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Section of Molecular Oncology & Developmental Therapeutics
DBBS - Molecular Cell Biology
DBBS - Molecular Genetics and Genomics
DBBS - Cancer Biology
Mentorship to Enhance Development in Academia Program
Research output
:
Contribution to journal
›
Article
›
peer-review
60
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Role of WNT7B-induced noncanonical pathway in advanced prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Advanced Prostate Cancer
100%
Non-canonical Pathway
100%
Wnt7b
100%
Androgen Receptor
42%
Prostate Cancer
28%
Androgen Signaling
28%
Osteoblastic
28%
Receptor Targets
28%
Androgen Deprivation Therapy
28%
Castration-resistant Prostate Cancer Cells
28%
Prostate Cancer Cells
14%
Further Analysis
14%
Bone Response
14%
Androgens
14%
Differentiation in Vitro
14%
Cell-cell Interaction
14%
Cancer Resistance
14%
Castration-resistant Prostate Cancer
14%
Cancer Xenograft
14%
Androgen-independent
14%
Prostate Development
14%
Osteoblast Differentiation
14%
Response Characteristics
14%
Castration Resistance
14%
Castration-resistant
14%
Osteolytic Metastasis
14%
Protein Kinase C Isozymes
14%
Medicine and Dentistry
Prostate Cancer
100%
Androgen Receptor
55%
Cancer Cell
33%
Androgen
33%
Castration Resistant Prostate Cancer
33%
In Vitro
11%
Protein Kinase C
11%
Bone Metastasis
11%
Osteoblast
11%
Cell Interaction
11%
Tumor Xenograft
11%
Cancer Resistance
11%
Androgen Deprivation Therapy
11%
Isoenzyme
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen Receptor
55%
Androgen
44%
Castration Resistant Prostate Cancer
33%
Protein Kinase C
11%
Bone Metastasis
11%
Cancer Resistance
11%
Isoenzyme
11%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
100%
Cancer Cell
60%
Osteoblast
20%
Isoenzyme
20%
Cell-Cell Interaction
20%
Protein Kinase C
20%